[901]
Metastatic neuroblastoma of the mandible mimicking osteogenic ...
[206,4 KB]
From [www.ada.org.au] Last viewed: 13.07.2004
Abstract
This paper presents a case of a neuroblastoma of
the adrenal gland metastazing to the mandible of a
21 month old infant, which presented radio-
graphically as the so-called ‘sun-ray’ appearance,
c h a r a c t e r i s t i c of osteogenic sarcoma.
Key words:
Metastatic
neuroblastoma ,
‘sun-ray’
appearance, pattern recognition, osteogenic sarcoma,
case report.
(Received for publication July 1996. Revised November
1996. Accepted November 1996.)
Introduction
Metastatic lesions produce no pathognomonic
r o e n t g e n o graphic appearance, although most
metastases produce osteolytic lesions and thus
appear as radiolucencies on the roentgenogram.
Certain tumours produce osteoblastic lesions or
lesions characterized by production of bone.
1
In this
paper the radiographic appearance of a case of
metastatic neuroblastoma ...
[902]
Caffeine Induces Apoptosis in Human Neuroblastoma Cell Line SK-N ...
[116,0 KB]
From [jkms.kams.or.kr] Last viewed: 13.07.2004
Web Immagini Gruppi Directory News
Ricerca avanzata Preferenze
Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL
Web
La ricerca di - cache:WrBCzR_6DJEJ:jkms.kams.or.kr/2002/pdf/10674.pdf allintitle: neuroblastoma filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti:
- Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave.
©2004 ...
[903]
Congenital Neuroblastoma with Multiple Metastases :
[200,7 KB]
From [jkms.kams.or.kr] Last viewed: 13.07.2004
INTRODUCTION
Neuroblastoma is the most common malignant tumor in
the neonatal period, and accounts for 20% of all malignancies
duing period (1). Congenital neuroblastoma is uncommon,
and about 80 cases have been described (2). Although neuro-
blastoma can metastasize in utero, congenital neuroblas-
tomas with multiple metastases are rare. We present a case of
congenital neuroblastoma with multiple metastases, which is
the first case among Koreans.
CASE REPORT
He was born by cesarian section at 38 weeks of gestation. He
weighed 2,350 g and had Apgar score of 4 at 5 min. Mater-
nal history (27-yr-old, 1-0-0-1) was unremarkable. Prenatal
ultrasound at 36 weeks, gestation had shown an increased fetal
abdominal circumference, but no abdominal mass was report-
ed. During physical examination, the baby was pale and ta-
chypnoic. The abdomen was markedly distended, while mul- ...
[904]
Autologous Stem Cell Transplantation for the Treatment of ...
[101,9 KB]
From [jkms.kams.or.kr] Last viewed: 13.07.2004
INTRODUCTION
The herpes simplex virus (HSV) thymidine kinase (TK) gene
is a suicide gene under study in both experimental and clin-
ical protocols as a treatment for human cancer. Transfer of the
TK gene into tumor cells results in tumor cell death upon
exposure to the antiviral prodrug ganciclovir (GCV), as the
TK protein phosphorylates the prodrug into a toxic nucleotide
analog whose incorporation into nascent DNA results in ter-
mination of DNA replication. Despite the in vivo HSV-TK
gene transduction of approximately 10-20% of tumor cells,
complete tumor eradication occurs in tumors (1). This phe-
nomenon is probably due to a
‘bystander effect’associated
uniquely with the HSV-TK/GCV system. It includes the
transfer of the toxic metabolic products of GCV through gap
junction (2), which have recently been shown to be dependent
on connexin-mediated intercellular communication (3-5), the ...
[905]
Myeloablative Treatment Supported by Autologous Stem Cell Infusion ...
[126,1 KB]
From [jkms.kams.or.kr] Last viewed: 13.07.2004
Web Immagini Gruppi Directory News Novità!
Ricerca avanzata Preferenze
Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL
Web
La ricerca di - cache:XvmjWZQSWigJ:jkms.kams.or.kr/2003/pdf/04184.pdf allintitle: neuroblastoma filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti:
- Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave.
...
[906]
University of Michigan Comprehensive Cancer Center Childhood ...
[126,9 KB]
From [www.cancer.med.umich.edu] Last viewed: 13.07.2004
Last Revised: 3/8/2004
UM Cancer Center
Patient Education Document #0007
Mar04 Ed.
Online version: http://www.cancer.med.umich.edu/learn/percpathways.htm
University of Michigan Comprehensive Cancer Center
Patient Education Resource Center (PERC)
INFORMATION GUIDE
Childhood Cancer: Neuroblastoma
The purpose of this information guide is to help parents of children newly diagnosed with Neuroblastoma find
sources of information and support. This list is not meant to be comprehensive, but rather to provide starting
points for information seeking. The materials can be found at the Patient Education Resource Center at the
University of Michigan Comprehensive Cancer Center in room B1-361.
Article
Available in the Patient Education Resource Center level B1 room 361
Reynolds, Patrick C. Treating High-Risk Neuroblastoma at the ...
[907]
Neuroblastoma
[30,3 KB]
From [public2.bcm.tmc.edu] Last viewed: 13.07.2004
Texas Children?s Cancer Center
and Hematology Service
Neuroblastoma
What is neuroblastoma ?
Neuroblastoma is a type of cancer that arises from
the autonomic nervous system in the body. The
autonomic nervous system controls things like
blood pressure in the arteries, movement within
the intestines, sweating, and many other activities.
Parts of the autonomic nervous system lie along
the spine and in the adrenal glands above the
kidneys. Neuroblastoma may start in any of these
areas. Most often, it starts in the abdomen—either
in the adrenal glands or around the spinal cord.
Neuroblastoma can also start around the spinal
cord in the chest, neck, or pelvis. It can spread to
lymph nodes, liver, skin, bone marrow, bone,
lungs and brain.
Neuroblastoma is one of the most common kinds
of cancer in children. It occurs most often in ba-
bies and ...
[908]
Transformation of a Neuroblastoma Cell Line by constitutive PAX5 ...
[7,9 KB]
From [www.pharmacenter.ch] Last viewed: 13.07.2004
Poster no. 4
Transformation of a Neuroblastoma Cell Line by constitutive PAX5 expression
Baumann Florian , Maag Charlotte and Himmelmann Andreas W.
University Hospital Zurich, Medical Oncology, Zurich
PAX5 is an essential transcription factor for B-cell maturation and the development of the nervous system.
In addition PAX5 has been implicated in the genesis of certain lymphomas and medulloblastoma.
For the first time we detected PAX5 expression in neuroblastoma cell lines. Interestingly, PAX5 expression
was strictly restricted to the malignant N-type neuroblastoma cell lines, but was absent in all non-
tumorigenic S-type sublines. Thus, neuroblastoma cells presented a suitable model system to study the
oncogenic potential of PAX5. Independent clones of the S-type cell line CA-2E with constitutive
expression of PAX5-cDNA (PAX5
+
) showed clear phenotypic changes.
We observed a ...
[909]
Genome-wide Array CGH Analysis of Murine Neuroblastoma Reveals ...
[591,4 KB]
From [www.ucalgary.ca] Last viewed: 13.07.2004
[CANCER RESEARCH 63, 5266 –5273, September 1, 2003]
Genome-wide Array CGH Analysis of Murine Neuroblastoma Reveals Distinct
Genomic Aberrations which Parallel those in Human Tumors
1,2
Christopher S. Hackett,
3
J. Graeme Hodgson,
2
Mark E. Law, Jane Fridlyand, Kazutoyo Osoegawa, Pieter J. de Jong,
Norma J. Nowak, Daniel Pinkel, Donna G. Albertson, Ajay Jain, Robert Jenkins, Joe W. Gray, and
William A. Weiss
4
Departments of Neurology [C. S. H., W. A. W.], Pediatrics [C. S. H., W. A. W.], Neurological Surgery [C. S. H., W. A. W.], Laboratory Medicine [J. G. H., D. P., A. J., J. W. G.,
W. A. W.], Cancer Center [J. G. H., J. F., D. P., D. G. A., A. J., W. A. W.], and Cancer Research Institute [J. F., D. G. A., A. J., J. W. G.], University of California, San Francisco,
California 94143-0114; Department of Laboratory Medicine and Pathology, Mayo ...
[910]
Bystander-Mediated Regression of Murine Neuroblastoma via ...
[132,5 KB]
From [jkms.kams.or.kr] Last viewed: 13.07.2004
INTRODUCTION
The herpes simplex virus (HSV) thymidine kinase (TK) gene
is a suicide gene under study in both experimental and clin-
ical protocols as a treatment for human cancer. Transfer of the
TK gene into tumor cells results in tumor cell death upon
exposure to the antiviral prodrug ganciclovir (GCV), as the
TK protein phosphorylates the prodrug into a toxic nucleotide
analog whose incorporation into nascent DNA results in ter-
mination of DNA replication. Despite the in vivo HSV-TK
gene transduction of approximately 10-20% of tumor cells,
complete tumor eradication occurs in tumors (1). This phe-
nomenon is probably due to a
‘bystander effect’associated
uniquely with the HSV-TK/GCV system. It includes the
transfer of the toxic metabolic products of GCV through gap
junction (2), which have recently been shown to be dependent
on connexin-mediated intercellular communication (3-5), the ...
[911]
An Immune Boost against Neuroblastoma— An Immune Boost against ...
[294,1 KB]
From [www.hopestreetkids.org] Last viewed: 13.07.2004
3
body’s white cells — a hypothesis that has
since been proven at the bench — and is
now being tested at the bedside.
In animal studies Cheung used purified
glucan taken from barley and oats for oral
administration. “We tested their effec-
tiveness in laboratory
mice carrying neurob-
lastoma tumors,” Che-
ung explains. “When
used alone it was not
effective. But when we
used it along with the
anti-GD2 mon-
oclonal anti-
body 3F8,
tumor growth
was nearly total-
ly suppressed.”
Cheung believes
that when the glu-
can molecule
arrives at certain
parts of the gastrointestinal tract, it attach-
es to “receptor cells,” activating them to
release cancer-fighting leukocytes to attack
the tumor. This action, however, is
dependent on the antibodies that lay down
certain proteins on the surface of tumor
cells.
“They are natural ...
[912]
Neuroblastoma Incidence in Illinois: 1986-1997
[13,9 KB]
From [www.idph.state.il.us] Last viewed: 13.07.2004
Neuroblastoma Incidence in Illinois: 1986-1997
Neuroblastoma is one of the most commonly diagnosed solid tumors in young children. The disease originates from
neural cell ectoderm that gives rise in the developing fetus to the sympathetic nervous system, the adrenal medulla, and the
adrenergic and cholinergic neuroblasts along the sympathetic chain and cranial ganglia. The annual incidence rate among
children under 15 years of age in the United States is nine to 11 cases per million (1). In Illinois, according to data reported
to the Illinois State Cancer Registry from 1986 through 1997, the annual incidence rate was 10.5 per million. Neuroblastoma
incidence at state and county levels has been reported previously for 1986 through 1994 by the Illinois State Cancer
Registry (2). The current study updates the previous report through adding three more recent years of data to the original
analysis.During the 12-year period ...
[913]
Insulin-like growth factor-I signaling in human neuroblastoma ...
[628,6 KB]
From [www.nature.com] Last viewed: 13.07.2004
Insulin-like growth factor-I signaling in human neuroblastoma cells
Bhumsoo Kim*
,1
, Cynthia M van Golen
1
and Eva L Feldman
1
1
Department of Neurology, University of Michigan, 4414 Kresge III, 200 Zina Pitcher Place, Ann Arbor, MI 48109-0588, USA
Neuroblastoma is a heterogeneous tumor consisting of N
(neuronal) and S (stromal) cells. We report that more
tumorigenic and motile N cells express higher levels of
IGF-I receptor (IGF-IR) than less tumorigenic, more
adherent S cells. Shc, one of the two major docking
partners of IGF-IR, is equally expressed in N and S cell
lines. IGF-I treatment phosphorylates Shc in N cells, but
only weakly activates Shc in S cells. Expression of the
second partner, insulin receptor substrate (IRS), is cell
type specific. S cells exclusively express IRS-1 that
undergoes sustained phosphorylation by IGF-I. In ...
[914]
The RET and TRKA pathways collaborate to regulate neuroblastoma ...
[630,9 KB]
From [www.nature.com] Last viewed: 13.07.2004
The RET and TRKA pathways collaborate to regulate neuroblastoma
differentiation
Suzanne Peterson
1
and Emil Bogenmann
1
*
1
Childrens Hospital Los Angeles, Division of Hematology Oncology, 4650 Sunset Boulevard, Los Angeles, CA, USA
Neuroblastoma (NB) is a childhood cancer that arises in
the adrenal gland and often shows differentiated neuronal
and glial elements. The RET receptor signal pathway is
functional in most NB, while loss of nerve growth factor
(NGF) receptor (trkA) gene expression correlates with an
aggressive phenotype. Thus, we hypothesized that the
RET and TRKA signal pathways collaborate to instruct
NB differentiation, reminiscent of normal neuronal
maturation. Here, we demonstrate that activation of the
RET receptor by glial cell line-derived neurotrophic factor
(GDNF) increases expression of the RET receptor
complex in ...
[915]
El tribromofenol induce la diferenciacion de celulas de ...
[370,7 KB]
From [www.us.es] Last viewed: 13.07.2004
Tribromophenol induces the differentiation of SH-SY5Y human
neuroblastoma cells in vitro
J.C. Ri´os
a, b
,G. Repetto
a, c,
* ,A. Jos
a
,A. del Peso
a
,M. Salguero
a
,A. Camea´n
c
,
M. Repetto
a, c
a
National Institute of Toxicology, PO Box 863, 41080, Sevilla, Spain
b
CITUC, School of Medicine, Pontificia Universidad Cato´lica de Chile, Chile
c
Area of Toxicology, Universidad de Sevilla, Sevilla, Spain
Accepted 31 May 2003
Abstract
Tribromophenol is a pesticide with fungicide activity,presently used as a replacement of pentachlorophenol as a wood pre-
servative,and as a flame retardant in electronic and electrotechnical devices. Retinoic acid differentiated and non-differentiated SH-
SY5Y human neuroblastoma cell cultures were ...
[916]
Genomic lesions in neuroblastoma and breast cancer Neuroblastoma ...
[239,4 KB]
From [www.dkfz-heidelberg.de] Last viewed: 13.07.2004
390
Research Program H
Genome Research and Bioinformatics
Division H0400
Tumour Genetics
DKFZ 2003: Research Report 2001/2002
Scientists
Dr. Hanxiang An (-12/02)
Dr. Larissa Savelyeva
Dr. Christian Praml (-3/01) Dr. Frank Westermann
Dr. Isabel Matzner
Guest Scientist
Michail Repin (3/02-, Moscow, Russia)
Graduate Students
Katrin Arnold (1/01-)
Stefan Brouwers
Andreas Claas (-4/01)
Anne Fechter (1/02-)
Kai-Oliver Henrich
Min-Kyoung Kim (10/00-)
Britta Mädge (-8/01)
Tobias Paffhausen (10/02-)
Andrea Pillmann (-4/01)
Vitaliya Sagulenko (10/01-)
Jens Schmitt (2/02-)
Isabel Wittke (-5/02)
Ruprecht Wiedemeyer
Sabine Zitzmann (-6/02)
Assistants
Young-Gyu Park
Marc Matuszewska (7/02-)
Secretary
Cornelia Kirchner
Genes, chromosomes and cancer
Genomic lesions are considered to be central players in ...
[917]
ApoE Synthesis in Human Neuroblastoma Cells
[223,7 KB]
From [perso.wanadoo.fr] Last viewed: 13.07.2004
1
Cancer Letters, Special Issue 2003: “Neural development and Cancer” (Mini-review)
Comprehensive genomics linking between neural development
and cancer: Neuroblastoma as a model
Akira Nakagawara*, Miki Ohira
Division of Biochemistry, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuoh-ku,
Chiba 260-8717, Japan
* Corresponding author. Tel: +81-43-264-5431; Fax: +81-43-265-4459.
E-mail address: akiranak@chiba-ccri.chuo.chiba.jp (A. Nakagawara)
Page 2
2
Abstract
Cancer cells are derived from their precursor cells, which normally develop to the matured
cells to form individual organs. Neuroblastoma , one of the most common pediatric solid
tumors, originates from possible cancer stem cells derived from the neural crest. During the
development, neural crest cells segregate into several lineages such as sensory, enteric and
...
[918]
Neuroblastoma
[176,9 KB]
From [www.mc.vanderbilt.edu] Last viewed: 13.07.2004
Neuroblastoma
ANBL00B1
Biology
Perinatal
Low Risk
Intermediate
Relapse
High Risk
COG P9641
Primary
Surgical
Therapy
COG A3961
CTX, VP-16,
CBDCA, DOX
COG A3973
Phase III:
PBSCT
ANBL00P2
Expectant
Observation
K E Y
Pending
Suspended
Open
Revised 11/19/03
Team Leader Signature and Date
COG P9761
Phase II:
Irinotecan
*1st Priority
COG P9963
Phase II:
Rebeccamycin
Analog
*2nd Priority
ADVL 0122
Phase II:
Gleevec
*3rd Priority
ANBL-0321
Phase II:
Fenretinide
*4th Priority
[919]
Experimental treatment of human neuroblastoma using live ...
[513,8 KB]
From [147.52.72.117] Last viewed: 13.07.2004
Abstract.
Neuroblastoma , originated from neural crest cells, is
the most common extracranial solid tumor in childhood. In the
present study, we evaluated
in vitro the oncolytic effect of live-
attenuated poliovirus on human neuroblastoma cell lines, and
in vivo its therapeutic efficacy in human neuroblastoma -
bearing athymic mice. Live-attenuated poliovirus killed 27
(93%) of 29 established neuroblastoma cell lines in vitro . It
induced cleavage of eukaryotic translation initiation factor 4G,
leading to cell death through a mechanism involving activation
of caspase-9, caspase-3 and poly(ADP-ribose)polymerase. For
the in vivo experiments, an animal model was established
using athymic mice xenotransplanted with SJ-N-JF
neuroblastoma cells on both flanks. Inoculation of live-
attenuated poliovirus into one of the two tumors caused a
dramatic and complete regression of ...
[920]
Transfecting a Human Neuroblastoma Cell Line with Monster Green ...
[106,9 KB]
From [www.promega.com] Last viewed: 13.07.2004
Neuroblastoma
ANBL00B1
Biology
Perinatal
Low Risk
Intermediate
Relapse
High Risk
COG P9641
Primary
Surgical
Therapy
COG A3961
CTX, VP-16,
CBDCA, DOX
COG A3973
Phase III:
PBSCT
ANBL00P2
Expectant
Observation
K E Y
Pending
Suspended
Open
Revised 11/19/03
Team Leader Signature and Date
COG P9761
Phase II:
Irinotecan
*1st Priority
COG P9963
Phase II:
Rebeccamycin
Analog
*2nd Priority
ADVL 0122
Phase II:
Gleevec
*3rd Priority
ANBL-0321
Phase II:
Fenretinide
*4th Priority
[921]
Detecting Caspase Activity in Stauosporine-Treated Human ...
[93,2 KB]
From [www.promega.com] Last viewed: 13.07.2004
Neuroblastoma
ANBL00B1
Biology
Perinatal
Low Risk
Intermediate
Relapse
High Risk
COG P9641
Primary
Surgical
Therapy
COG A3961
CTX, VP-16,
CBDCA, DOX
COG A3973
Phase III:
PBSCT
ANBL00P2
Expectant
Observation
K E Y
Pending
Suspended
Open
Revised 11/19/03
Team Leader Signature and Date
COG P9761
Phase II:
Irinotecan
*1st Priority
COG P9963
Phase II:
Rebeccamycin
Analog
*2nd Priority
ADVL 0122
Phase II:
Gleevec
*3rd Priority
ANBL-0321
Phase II:
Fenretinide
*4th Priority
[922]
LACK OF PHOSPHOLIPASE A MUTATIONS IN NEUROBLASTOMA, MELANOMA AND ...
[62,7 KB]
From [dceg2.cancer.gov] Last viewed: 13.07.2004
LACK OF PHOSPHOLIPASE A
2
MUTATIONS IN NEUROBLASTOMA , MELANOMA
AND COLON-CANCER CELL LINES
Frank G. H
ALUSKA
1
*, Carol T
HIELE
3
, Alisa G
OLDSTEIN
4
, Hensin T
SAO
5
, Eric P. B
ENOIT
1
and David H
OUSMAN
2
1
Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA
2
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA
3
Cell and Molecular Biology Section, Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
4
Genetic Epidemiology Branch, National Institutes of Health, Bethesda, MD, USA
5
Department of Dermatology, Harvard Medical School, Boston, MA, USA
A candidate murine tumor-suppressor ...
[923]
Neuroblastoma
[39,0 KB]
From [xpedio02.childrenshc.org] Last viewed: 13.07.2004
Neuroblastoma Imaging Using a Combined CT
Scanner–Scintillation Camera and
131
I-MIBG
H. Roger Tang, Angela J. Da Silva, Katherine K. Matthay, David C. Price, John P. Huberty, Randall A. Hawkins,
and Bruce H. Hasegawa
Departments of Radiology and Pediatrics, University of California, San Francisco, California
High-dose administration of
131
I-metaiodobenzylguanidine (
131
I-
MIBG) continues to be a promising treatment for neuroblastoma .
However, currently used methods of estimating
131
I-MIBG uptake
in vivo may be too inaccurate to properly monitor patient radiation
exposure doses. To improve localization and uptake measure-
ments over currently practiced techniques, we evaluated different
methodologies that take advantage of the correlated patient data
available from a combined CT–scintillation camera imaging sys-
tem. ...
[924]
Neuroblastoma
[122,2 KB]
From [www.orpha.net] Last viewed: 13.07.2004
Neuroblastoma
Authors: Doctors Matthias Schell
1
and Christophe Bergeron
Creation date: October 2003
Scientific Editor: Professor Thierry Philip
1
Centre Léon Bérard, Service de Pédiatrie, 69373 Lyon cedex 08, France. schell@lyon.fnclcc.fr
Abstract
Key-words
Disease name and synonyms
Definition
Differential diagnosis
Etiology
Clinical description
Outcome
Diagnostic methods
Epidemiology
Treatment
Unresolved questions
References
Abstract
Neuroblastoma is a malignant tumour of neural crest cells which give rise to the sympathetic nervous
...
[925]
SYDNEY DUNGAN NEUROBLASTOMA FUNDRAISER
[26,1 KB]
From [www.sydneydungan.com] Last viewed: 13.07.2004
neuroblastoma
For Immediate Release Press Contact:
Mark Dungan
817-738-3923
&nbs...
[926]
Pyrazoloacridine Is Active in Multidrug-resistant Neuroblastoma ...
[188,7 KB]
From [www.nant.org] Last viewed: 13.07.2004
Pyrazoloacridine Is Active in Multidrug-resistant Neuroblastoma
Cell Lines with Nonfunctional p53
1
Nino Keshelava, Denice Tsao-Wei, and
C. Patrick Reynolds
2
Division of Hematology-Oncology, Children’s Hospital Los Angeles,
and Departments of Pediatrics [N. K., C. P. R.], Pathology [C. P. R.],
and Preventive Medicine [D. T-W.], University of Southern California
Keck School of Medicine, Los Angeles, California 90033
ABSTRACT
Purpose : The purpose of this study was to determine the
activity of pyrazoloacridine (PZA) in neuroblastomas that
have acquired high-level resistance to multiple drugs (not
associated with multidrug resistance-associated protein or
P-glycoprotein) during therapy, including those with loss of
p53 function.
Experimental Design : We determined the activity of
PZA in 12 drug-sensitive and 10 multidrug-resistant (MDR) ...
[927]
Treatment of Experimental Neuroblastoma with Angiogenic Inhibitors
[1026,7 KB]
From [publications.uu.se] Last viewed: 13.07.2004
Calcium Protects Differentiating Neuroblastoma cells During 50
Hz Electromagnetic Radiation
R. Tonini, M.D. Baroni E. Masala, M. Micheletti
+
, A. Ferroni, and M. Mazzanti
#
.
Dipartimento di Fisiologia e Biochimica Generali, I
a
Università di Milano, I-20133 Milano,
Italy.
+
DIBIT, HSR, I-20100 Milano, Italy.
#
Dipartimento di Biologia Cellulare e dello
Sviluppo, Università “La Sapienza”, I-00185 Roma, Italy.
Running title: Magnetic field modulates NG 108-15 cells differentiation
Keywords: extremely low frequency electromagnetic field (ELF-EMF),
neuroblastomaXglioma cells (NG 108-15), BT2-cAMP induced differentiation, resting
potential modulation, Calcium current.
Corresponding author: Prof. Michele Mazzanti
Dipartimento di Biologia Cellulare e dello Sviluppo Università "La Sapienza"
P.le Aldo Moro 5, I-00185, ...
[928]
IMPACT OF RADIOTHERAPY FOR HIGH-RISK NEUROBLASTOMA: A CHILDREN’S ...
[159,2 KB]
From [www.nant.org] Last viewed: 13.07.2004
doi:10.1016/S0360-3016(02)04506-6
CLINICAL INVESTIGATION
Pediatrics
IMPACT OF RADIOTHERAPY FOR HIGH-RISK NEUROBLASTOMA :
A CHILDREN’S CANCER GROUP STUDY
D
APHNE
A. H
AAS
-K
OGAN
, M.D.,* P
ATRICK
S. S
WIFT
, M.D.,
†
M
ICHAEL
S
ELCH
, M.D.,
‡
G
ERALD
M. H
AASE
, M.D.,
§
R
OBERT
C. S
EEGER
, M.D.,
¶
R
OBERT
B. G
ERBING
, M.A.,
#
D
ANIEL
O. S
TRAM
, P
H
.D.,
**
AND
K
ATHERINE
K. M
ATTHAY
, M.D.
††
Departments of *Radiation Oncology and
††
Pediatrics, University of California ...
[929]
Detection of Amplification in Neuroblastoma Using Polymerase Chain ...
[585,0 KB]
From [medind.nic.in] Last viewed: 13.07.2004
Detection of Amplification in Neuroblastoma Using
Polymerase Chain Reaction and Its Impact on Survival
A P
RATAP
, S S
INHA
, DK G
UPTA
Molecular biology has revolutionized the medicine and added a new
dimension to our knowledge of disease processes, especially in the
field of oncology. Proto oncogenes are proteins normally present in
the genome and they may be converted to oncogenes by mutations,
rearrangements, translocation and deletion. One such
protooncogene is the N-myc proto-oncogene seen in
neuroblastoma . Amplification of the N-myc oncogene identifies a
group of patients who have a poor prognosis. At present, it is
generally agreed that the amplification of N-myc is still the most
important prognostic factor to be investigated in every patient with
neuroblastoma because of it’s reliability as a prognostic indicator.
There are many conventional ...
[930]
The amazing race against Neuroblastoma.
[123,3 KB]
From [thedarkerside.to] Last viewed: 13.07.2004
The amazing race against Neuroblastoma .
When: July 26
th
2003
Where: All over Toronto
Why: Joe made me do it.
This was sort of a “fun” event. Nothing to serious really, just for a good cause. So I
figured “why not”. The guys who put this on pretty much wanted to create a small version
of the TV Series “The Amazing Race” and in a total of 24 teams was supposed to hunt
down clues all over downtown Toronto.
Joe came up with the perfect team name: “The Eh! Team” (If you don't get it you're not
Canadian or have not been here).
So on Saturday morning at 9:30am we all met at the place of the first clue. The
description for this read as follows:
'To start the race off with ease, We made the first
clue a breeze. At the court yard of King and Bay,
Meet us there, where the cows lay.'
So, at 9:30 I strolled onto the plaza behind the Toronto Dominion Centre and a minute ...